Home  >  TopNews
TopNews
  IPA criticises GIPC's continued tirade against India for keeping India on 'Priority Watch List',   February 17, 2018
  Indian Pharmaceutical Alliance appeals to USTR to remove India from Priority Watch List,   February 09, 2018
  Origiin IP calls to file ANDA application with the US FDA to thwart patent infringement risk for generic drug approval,   January 17, 2018
  K&S Partners sees grant of patent has no direct correlation to access life-saving medicines,   November 10, 2017
  ICMR releases Handbook on IPR & Technology Transfer to step up awareness among scientists,   October 30, 2017
  Health ministry can invoke provision of Patent Act to reduce cost of procurement of Prevnar 13 under UIP: says Dr Nair,   October 30, 2017
  MSF appeals to Korea, Japan to withdraw proposals hindering access to generic drugs & vaccines from RCEP negotiations,   October 25, 2017
  Indian Patent Act achieved balance between drug innovators & public health: Dr BR Jagashetty,   October 13, 2017
  Experts see value of pharma patents in India can encourage research for novel drugs,   October 06, 2017
  MSF fears some provisions in India-EFTA trade talks will erode India’s ability to supply generic drugs across developing world,   May 31, 2017
  Civil society organizations ask University of California to withdraw efforts to obtain patent on prostate cancer drug enzalutamide in India,   May 29, 2017
  DSM Sinochem wins Indian patent infringement case against Sinopharm Weiqida on amoxicillin trihydrate,   May 24, 2017
  Delhi High Court stays its earlier order permitting Natco Pharma to export Bayer’s patented drug Nexavar,   May 23, 2017
  DIPP, WIPO to set up technology and innovation support centres,   May 10, 2017
  After India, I-MAK files legal challenge against Gilead’s hepatitis C drug sofosbuvir in China,   April 21, 2017
  MSF files patent challenge on hepatitis C drug sofosbuvir with European Patent Office,   March 31, 2017
  Civil society groups urge Swiss negotiators not to include harmful IP measures in India-EFTA negotiations,   March 24, 2017
  Civil society, patient groups call on Japan and South Korea to withdraw harmful proposals from RCEP negotiations,   February 24, 2017
  US Chamber ranks India at bottom in its IP report, Indian Pharmaceutical Alliance terms it flawed assumption,   February 21, 2017
  NGOs file 4 patent cases to challenge patent on hepatitis C drugs sofosbuvir, velpatasvir and daclatasvir,   February 15, 2017

 Back
 
Chemspec_India-2018
CPHI18_banner_150x6
CPhI_Japan_150x60_2018
DIRQ_150x60_2018
Pharmabiz: PPM_150x60_2018
CPHI-SEA-2018-150x60-Register-Now-STAT-English-v1
MTWCbanners_150X60_08
VF118_Banner_150x60_E_D2
duphat_150x60
IPJPI18_150x60en_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |